Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cue Biopharma, Inc.

0.7249
+0.00110.15%
Post-market: 0.74420.0193+2.66%19:53 EDT
Volume:120.37K
Turnover:88.12K
Market Cap:54.62M
PE:-1.11
High:0.7514
Open:0.7300
Low:0.7200
Close:0.7238
Loading ...
Mar 18, 2021

Major Issues Report

8-K - Current report
Mar 09, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 09, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 16, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 29, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Nov 19, 2020

Major Issues Report

8-K - Current report
Nov 09, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 17, 2020

Major Issues Report

8-K - Current report
Aug 24, 2020

Major Issues Report

8-K - Current report
Aug 10, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 15, 2020

Major Issues Report

8-K - Current report
Jun 26, 2020

Major Issues Report

8-K - Current report
Jun 22, 2020

Major Issues Report

8-K - Current report
Jun 05, 2020

Major Issues Report

8-K - Current report
May 19, 2020

Major Issues Report

8-K - Current report
May 07, 2020

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Apr 29, 2020

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
Apr 21, 2020

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership